Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group

Treatment options remain limited for patients with autoimmune hepatitis (AIH), while there are still concerns over the consequences of long-term corticosteroid use. A few studies have suggested a role for B cell-driven autoimmune liver injury in AIH. This multicentre, international retrospective coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Than, Nwe Ni, Hodson, James, Schmidt-Martin, Daniel, Taubert, Richard, Wawman, Rebecca E., Botter, Meemee, Gautam, Nishant, Bock, Kilian, Jones, Rebecca, Appanna, Gautham D, Godkin, Andrew, Montano-Loza, Aldo J., Lammert, Frank, Schramm, Christoph, Manns, Michael P., Swain, Mark, Burak, Kelly W., Adams, David H., Hirschfield, Gideon M, Oo, Ye Htun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005655/
https://www.ncbi.nlm.nih.gov/pubmed/32039395
http://dx.doi.org/10.1016/j.jhepr.2019.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005655/
https://www.ncbi.nlm.nih.gov/pubmed/32039395
http://dx.doi.org/10.1016/j.jhepr.2019.10.005

Ejemplares similares